BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Prologue Research International Announces New Company Appointments


11/9/2007 7:45:44 AM

Prologue is pleased to announce the arrival of our new Vice President of Clinical Operations, Robert A. Stude. Mr. Stude brings with him nearly 25 years of experience in the pharmaceutical industry, including over 15 years in the CRO realm. As VP of Clinical Operations, his roles will include overseeing the monitoring services, site services, and clinical services groups as well as interfacing with the Project Management and Business Development departments to both insure the quality, on-time progression of current studies and help secure new business opportunities for future trials.

Prior to joining Prologue, Mr. Stude held various positions at pharmaceutical and CRO companies, most recently as a Senior Director of Monitoring and Clinical Services for Integrium Cardiovascular Research and prior to that as Senior Director of Clinical Services for i3 Research. Prologue wholeheartedly welcomes him to the team and looks forward to his guidance as we continue to grow as ‘The Oncology CRO’.

Additionally, Prologue is excited to announce the promotion of Phillip L. Banks to Senior Vice President of Biostatistics and Data Management. Mr. Banks is an M.S. statistician who has designed and analyzed numerous cancer clinical trials during his nearly 25 years in the biostatistical/clinical research field. He is now responsible for overseeing the activities of the Biostatistics, Data Management, and Information Technology departments.

Mr. Banks’ expertise includes providing strategic leadership for the design and analysis of cancer clinical trials, development of data management and statistical analysis plans, writing of clinical protocols, interpretation of clinical data for reports and publications, and senior review of technical documents. In his tenure, he has received numerous awards including an FDA Citation for exemplary leadership on an NDA for AML cancer patients, election as Fellow (F.R.S.) of the Royal Stastistical Society in London, and is one of the few biostatisticians who is a member of American Society of Clinical Oncology (ASCO).

For more information about these appointments or to learn more about Prologue’s full range of oncology clinical trial services, please visit our website at www.procro.com or email info@procro.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES